Clinical Trial: A Phase II Study of Frailty Score Guided Dose Intensity Adjustment of Polatuzumab Vedotin plus R-CHP in Elderly Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (Pola-FIT trial)(Japan)

Tokyo, June 2 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000057974) titled 'A Phase II Study Evaluating the Efficacy and Safety of Frailty Score Guided Dose Intensity Adjustment of Polatuzumab Vedotin plus R-CHP in Elderly Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma' on May 28

Study Type:

Interventional

Study Design:

Basic Design - Single arm Randomization - Non-randomized Blinding - Open -no one is blinded Control - Historical

Primary Sponser:

Institute - Clinical Research Unit, Tokyo Metropolitan Komagome Hospital, Tokyo Metropolitan Hospital Organization

Condition:

Condition - Diffuse large B-cell lymphoma Classification by malignancy - Malignancy Genomic informatio...